JP2010227106A5 - - Google Patents

Download PDF

Info

Publication number
JP2010227106A5
JP2010227106A5 JP2010108289A JP2010108289A JP2010227106A5 JP 2010227106 A5 JP2010227106 A5 JP 2010227106A5 JP 2010108289 A JP2010108289 A JP 2010108289A JP 2010108289 A JP2010108289 A JP 2010108289A JP 2010227106 A5 JP2010227106 A5 JP 2010227106A5
Authority
JP
Japan
Prior art keywords
immune
disease
test
biological sample
mammal
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2010108289A
Other languages
English (en)
Japanese (ja)
Other versions
JP2010227106A (ja
Filing date
Publication date
Application filed filed Critical
Publication of JP2010227106A publication Critical patent/JP2010227106A/ja
Publication of JP2010227106A5 publication Critical patent/JP2010227106A5/ja
Pending legal-status Critical Current

Links

JP2010108289A 2002-09-11 2010-05-10 免疫関連疾患の治療のための新規組成物と方法 Pending JP2010227106A (ja)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US41017402P 2002-09-11 2002-09-11

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
JP2004536436A Division JP2006512903A (ja) 2002-09-11 2003-09-10 免疫関連疾患の治療のための新規組成物と方法

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2012210684A Division JP2013051961A (ja) 2002-09-11 2012-09-25 免疫関連疾患の治療のための新規組成物と方法

Publications (2)

Publication Number Publication Date
JP2010227106A JP2010227106A (ja) 2010-10-14
JP2010227106A5 true JP2010227106A5 (https=) 2011-07-28

Family

ID=31994084

Family Applications (3)

Application Number Title Priority Date Filing Date
JP2004536436A Pending JP2006512903A (ja) 2002-09-11 2003-09-10 免疫関連疾患の治療のための新規組成物と方法
JP2010108289A Pending JP2010227106A (ja) 2002-09-11 2010-05-10 免疫関連疾患の治療のための新規組成物と方法
JP2012210684A Withdrawn JP2013051961A (ja) 2002-09-11 2012-09-25 免疫関連疾患の治療のための新規組成物と方法

Family Applications Before (1)

Application Number Title Priority Date Filing Date
JP2004536436A Pending JP2006512903A (ja) 2002-09-11 2003-09-10 免疫関連疾患の治療のための新規組成物と方法

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2012210684A Withdrawn JP2013051961A (ja) 2002-09-11 2012-09-25 免疫関連疾患の治療のための新規組成物と方法

Country Status (6)

Country Link
US (3) US20060281146A1 (https=)
EP (2) EP2116616A3 (https=)
JP (3) JP2006512903A (https=)
AU (2) AU2003267096B9 (https=)
CA (1) CA2497661A1 (https=)
WO (1) WO2004024076A2 (https=)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PT2343320T (pt) 2005-03-25 2018-01-23 Gitr Inc Anticorpos anti-gitr e as suas utilizações
US8591886B2 (en) 2007-07-12 2013-11-26 Gitr, Inc. Combination therapies employing GITR binding molecules
US20090136427A1 (en) * 2007-09-18 2009-05-28 La Jolla Institute For Allergy And Immunology LIGHT Inhibitors For Asthma, Lung and Airway Inflammation, Respiratory, Interstitial, Pulmonary and Fibrotic Disease Treatment
WO2010051502A2 (en) 2008-10-31 2010-05-06 Biogen Idec Ma Inc. Light targeting molecules and uses thereof
PE20170441A1 (es) 2014-06-06 2017-04-26 Bristol Myers Squibb Co Anticuerpos contra el receptor del factor de necrosis tumoral inducido por glucocorticoides (gitr) y sus usos
MX2017015260A (es) 2015-06-03 2018-02-19 Squibb Bristol Myers Co Anticuerpos anti receptor de factor de necrosis tumoral inducible por glucocorticoide (gitr) para diagnostico del cancer.
AU2016356780A1 (en) 2015-11-19 2018-06-28 Bristol-Myers Squibb Company Antibodies against glucocorticoid-induced tumor necrosis factor receptor (GITR) and uses thereof
CN110869392A (zh) 2017-05-16 2020-03-06 百时美施贵宝公司 用抗gitr激动性抗体治疗癌症
WO2019000144A1 (zh) * 2017-06-26 2019-01-03 深圳市博奥康生物科技有限公司 一种表达aitr基因的cho细胞及其应用
US12012441B2 (en) 2020-10-26 2024-06-18 Neptune Biosciences Llc Engineered human IL-21 cytokines and methods for using the same

Family Cites Families (33)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3773919A (en) 1969-10-23 1973-11-20 Du Pont Polylactide-drug mixtures
US4376110A (en) 1980-08-04 1983-03-08 Hybritech, Incorporated Immunometric assays using monoclonal antibodies
NZ207394A (en) 1983-03-08 1987-03-06 Commw Serum Lab Commission Detecting or determining sequence of amino acids
US4675187A (en) 1983-05-16 1987-06-23 Bristol-Myers Company BBM-1675, a new antibiotic complex
IL87737A (en) 1987-09-11 1993-08-18 Genentech Inc Method for culturing polypeptide factor dependent vertebrate recombinant cells
US5206161A (en) 1991-02-01 1993-04-27 Genentech, Inc. Human plasma carboxypeptidase B
PT616812E (pt) 1993-03-24 2000-04-28 Berlex Biosciences Combinacao de compostos anti-hormonais e moleculas de ligacao no tratamento do cancro
WO2000037640A2 (en) * 1998-12-22 2000-06-29 Genentech, Inc. Compositions and methods for the treatment of tumor
US6458939B1 (en) 1996-03-15 2002-10-01 Millennium Pharmaceuticals, Inc. Compositions and methods for the diagnosis, prevention, and treatment of neoplastic cell growth and proliferation
US5861308A (en) * 1996-08-21 1999-01-19 Ludwig Institute For Cancer Research Isolated nucleic acids associated with T cell activation and uses thereof
US5871965A (en) * 1996-10-25 1999-02-16 Incyte Pharmaceuticals, Inc. Guanylate binding proteins
WO2002000690A2 (en) * 2000-06-23 2002-01-03 Genentech, Inc. Compositions and methods for the diagnosis and treatment of disorders involving angiogenesis
WO2002008284A2 (en) * 2000-07-20 2002-01-31 Genentech, Inc. Compositions and methods for the diagnosis and treatment of disorders involving angiogenesis
WO2000073348A2 (en) * 1999-06-02 2000-12-07 Genentech, Inc. Methods and compositions for inhibiting neoplastic cell growth
US6069229A (en) * 1997-03-07 2000-05-30 Schering Corporation Mammalian proteinases; oxidoreductases; related reagents
WO2000078961A1 (en) * 1999-06-23 2000-12-28 Genentech, Inc. Secreted and transmembrane polypeptides and nucleic acids encoding the same
US6482923B1 (en) * 1997-09-17 2002-11-19 Human Genome Sciences, Inc. Interleukin 17-like receptor protein
AU2212299A (en) * 1998-01-05 1999-07-26 Genentech Inc. Compositions and methods for the treatment of tumor
NZ531664A (en) * 1998-09-01 2005-07-29 Genentech Inc Pro1317 polypeptides and sequences thereof with homology to the semaphorin B glycoprotein family
EP1119253A4 (en) * 1998-10-07 2005-12-21 Millennium Pharm Inc NEW SPECIFIC MOLECULES OF Th2 AND USES THEREOF
CA2384055A1 (en) * 1999-08-31 2001-03-08 Genentech, Inc. Compositions and methods for the treatment of immune related diseases
CA2491433A1 (en) * 1999-12-01 2001-06-07 Genentech, Inc. Secreted and transmembrane polypeptides and nucleic acids encoding the same
ES2380812T3 (es) * 1999-12-23 2012-05-18 Genentech, Inc. Polipéptidos homólogos a IL-17 y usos terapéuticos de los mismos
US20040034192A1 (en) * 2000-01-06 2004-02-19 Seishi Kato Human proteins having hyprophobic domains and dnas encoding these proteins
AU2001236638A1 (en) * 2000-02-04 2001-08-14 The Board Of Trustees Of The University Of Arkansas Evi27 gene sequences and protein encoded thereby
TWI322154B (en) * 2000-03-16 2010-03-21 Amgen Inc Il-17 receptor like molecules and uses thereof
US20030092881A1 (en) * 2000-05-24 2003-05-15 Gorman Daniel M. Mammalian receptor proteins; related reagents and methods
ES2349312T3 (es) * 2000-07-27 2010-12-29 Wyeth Llc Uso de anticuerpos antagonistas del receptor de il-10 para inhibir la inducción por il-tif/il-21 de proteínas de fase aguda.
WO2002018574A2 (en) * 2000-08-25 2002-03-07 North Shore-Long Island Jewish Research Institute Human interleukin-four induced protein
EP1346040A2 (en) * 2000-09-11 2003-09-24 Nuvelo, Inc. Novel nucleic acids and polypeptides
DE10055285A1 (de) * 2000-11-08 2002-06-06 Deutsches Krebsforsch Neue Marker für die Diagnose und Therapie von Tumoren
WO2004004649A2 (en) * 2002-07-08 2004-01-15 Genentech, Inc. Compositions and methods for the treatment of immune related diseases
JP2004121218A (ja) * 2002-08-06 2004-04-22 Jenokkusu Soyaku Kenkyusho:Kk 気管支喘息または慢性閉塞性肺疾患の検査方法

Similar Documents

Publication Publication Date Title
JP2012254093A5 (https=)
JP2010227106A5 (https=)
JP2010187677A5 (https=)
Zhu et al. Isolation and genetic characterization of bovine parainfluenza virus type 3 from cattle in China
Li Severe fever with thrombocytopenia syndrome: a newly discovered emerging infectious disease
JP2010162017A5 (https=)
CN102181581B (zh) 犬瘟热病毒、肠炎细小病毒和阿留申病毒的三重pcr试剂盒
JP2010220614A5 (https=)
RU2009142808A (ru) Новые полностью человеческие моноклональные антитела против vap-1
JP2009136300A5 (https=)
Gao et al. Construction and identification of a cDNA library for use in the yeast two-hybrid system from duck embryonic fibroblast cells post-infected with duck enteritis virus
CN103866046A (zh) 人疱疹病毒ebv和vzv检测试剂盒
Cui et al. Identification and genetic characterization of a novel circular single-stranded DNA virus in a human upper respiratory tract sample
Mäntynen et al. New enveloped dsRNA phage from freshwater habitat
JP2006521082A5 (https=)
CN110923217B (zh) 可识别2’-o-甲基化修饰rna的核糖核酸酶r及其应用
JP2013542713A5 (https=)
CN109563491B (zh) 新颖的副粘病毒及其用途
CN101921832A (zh) 用于检测致病疫霉的引物、试剂盒及检测方法
CN106148298A (zh) 水稻抗病相关基因OsDR11及其在水稻抗病中的应用
CN104611343B (zh) 分离的鲤抗病毒天然免疫蛋白trim32及抗病毒活性
CN102899425B (zh) 一种鸽疱疹病毒的检测试剂盒
CN114163521B (zh) 一种鉴别猪瘟病毒2.1亚型强毒株及其抗体的单克隆抗体
CN111172326B (zh) 一种体外检测rhTSG-6抗病毒活性的方法及rhTSG-6在抗病毒药物中的应用
CN103911389A (zh) 一种检测人呼吸道合胞病毒抗体的g和f蛋白的制备方法